Purpose: Symptoms secondary to hormonal changes significantly impact quality of life (QoL) in patients with cancer. This cross-sectional study examines prevalence of hypogonadism and its correlation with QoL and sexual dysfunction.
Patients And Methods: We collected blood and medical histories from 428 male patients with non-testosterone-related cancer at three cancer centers.